amifostine anhydrous has been researched along with Ascites in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Ascites: Accumulation or retention of free fluid within the peritoneal cavity.
Excerpt | Relevance | Reference |
---|---|---|
" Both amifostine and WR 1065 were rapidly cleared from the plasma (95% and 50% of the peak concentration within 1 h, respectively)." | 1.29 | Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient. ( Gall, HE; Korst, AE; van der Vijgh, WJ; Vermorken, JB, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Korst, AE | 1 |
Gall, HE | 1 |
Vermorken, JB | 1 |
van der Vijgh, WJ | 1 |
1 other study available for amifostine anhydrous and Ascites
Article | Year |
---|---|
Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient.
Topics: Adenocarcinoma; Amifostine; Ascites; Chromatography, High Pressure Liquid; Disulfides; Half-Life; Hu | 1996 |